SCHEMBL31322157

SCHEMBL31322157

O=C(O)c1ccc(CC2CN(CO)c3ccccc32)cc1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.44
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
SRD5A2 P31213 3/20 0.38
PRKACA P17612 1/20 0.38
PRKACG P22612 1/20 0.38
PRKACB P22694 1/20 0.38
RXRA P19793 1/20 0.37
RXRB P28702 1/20 0.37
RXRG P48443 1/20 0.37
LTA4H P09960 3/20 0.36
GRM5 P41594 1/20 0.36
GRM1 Q13255 1/20 0.36
TSHR P16473 1/20 0.35
S1PR5 Q9H228 1/20 0.35
LTB4R Q15722 1/20 0.35
LTB4R2 Q9NPC1 1/20 0.35
KDM1A O60341 1/20 0.35
ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31322148 0.83 ESR1 (0.47)
SCHEMBL31322144 0.82 HTR6 (0.48) MEN1KMT2APRKACAPRKACGPRKACB
SCHEMBL31322158 0.82 HCRTR2 (0.37) L3MBTL1MEN1KMT2AALDH1A1
SCHEMBL31322118 0.80 CCR5 (0.39)
SCHEMBL30099079 0.71 NOTUM (0.41) LTA4HALDH1A1
SCHEMBL2812600 0.63 KMT2A (0.56) MEN1KMT2ASRD5A2LTA4HTSHR
SCHEMBL5845746 0.61 SRD5A2 (0.63) L3MBTL1SRD5A2TSHRALDH1A1
SCHEMBL2783327 0.60 ALDH1A1 (0.48) L3MBTL1MEN1KMT2ASRD5A2TSHR
SCHEMBL13381339 0.60 TSHR (0.54) L3MBTL1SRD5A2TSHRALDH1A1
SCHEMBL2292715 0.60 ALDH1A1 (0.48) L3MBTL1MEN1KMT2ASRD5A2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4483866-A1 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF CANCER Makrolife Biotech GmbH (DE) 2025-01-01 EP claimed
EP-4483866-A1 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF CANCER Makrolife Biotech GmbH (DE) 2025-01-01 EP disclosed